for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Becton Dickinson and Co

bdx

Latest Trade

258.59USD

Change

1.79(+0.70%)

Volume

837,637

Today's Range

255.74

 - 

259.12

52 Week Range

208.62

 - 

264.74

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
256.80
Open
256.66
Volume
837,637
3M AVG Volume
21.33
Today's High
259.12
Today's Low
255.74
52 Week High
264.74
52 Week Low
208.62
Shares Out (MIL)
269.95
Market Cap (MIL)
69,324.23
Forward P/E
21.98
Dividend (Yield %)
1.20

Latest Developments

More

BD Says Thomas E. Polen Appointed Chief Executive Officer

Becton Dickinson Announces Q3 Earnings Per Share $1.51

Becton Dickinson And Co Sets Quarterly Dividend Of $0.77 Per Share

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Becton Dickinson and Co

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Industry

Medical Equipment & Supplies

Contact Info

1 Becton Dr

+1.201.8476800

http://www.bd.com/

Executive Leadership

Vincent A. Forlenza

Chairman of the Board, Chief Executive Officer

Thomas E. Polen

President, Chief Operating Officer

Christopher R. Reidy

Chief Financial Officer, Executive Vice President, Chief Administrative Officer

Betty D. Larson

Executive Vice President- Human Resources, Chief Human Resources

Samrat S. Khichi

Executive Vice President, General Counsel

Key Stats

1.82 mean rating - 17 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

12.5K

2017

12.1K

2018

16.0K

2019(E)

17.3K
EPS (USD)

2016

8.590

2017

9.480

2018

11.010

2019(E)

11.681
Price To Earnings (TTM)
64.13
Price To Sales (TTM)
4.05
Price To Book (MRQ)
3.23
Price To Cash Flow (TTM)
20.63
Total Debt To Equity (MRQ)
93.89
LT Debt To Equity (MRQ)
83.81
Return on Investment (TTM)
2.65
Return on Equity (TTM)
2.35

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up